
Telomeron can modify active ingredient molecules targeted at the cosmeceutical and nutraceutical sectors with its TELOS-SP technology
Telomeron Inc, a US-based company owned 90% by Exagon Industries Ltd and 10% by Gaia Inc (NASDAQ:GAIA),…
Telomeron Inc, a US-based company owned 90% by Exagon Industries Ltd and 10% by Gaia Inc (NASDAQ:GAIA),…